Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6669339 | 7079534 | F | 6669339-3 | 20100402 | 20100406 | EXP | A0801487A | GLAXOSMITHKLINE | 61 | YR | F | Y | 20100406 | PH | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6669339 | 1013452297 | PS | AVANDIA | 1 | ORAL | 4MG TWICE PER DAY | 021071 | ||||
| 6669339 | 1013452298 | C | ATENOLOL | 1 | |||||||
| 6669339 | 1013452299 | C | IMDUR | 1 | |||||||
| 6669339 | 1013452300 | C | PREMPRO | 1 | |||||||
| 6669339 | 1013452301 | C | PRILOSEC | 1 | |||||||
| 6669339 | 1013452302 | C | NORVASC | 1 | |||||||
| 6669339 | 1013452303 | C | XANAX | 1 | |||||||
| 6669339 | 1013452304 | C | LIPITOR | 1 | |||||||
| 6669339 | 1013452305 | C | PRAVACHOL | 1 | |||||||
| 6669339 | 1013452306 | C | AVAPRO | 1 | |||||||
| 6669339 | 1013452307 | C | PREVACID | 1 | |||||||
| 6669339 | 1013452308 | C | GLUCOVANCE | 1 | |||||||
| 6669339 | 1013452309 | C | GLYBURIDE | 1 | |||||||
| 6669339 | 1013452310 | C | FOLTX | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6669339 | 1013452297 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6669339 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6669339 | CORONARY ARTERY DISEASE |
| 6669339 | MYOCARDIAL INFARCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6669339 | 1013452297 | 20000101 |